W. Edwards

Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector.

D. Jolly, J. McCormack, W. Edwards, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer Gene Therapy.

Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly.

S. Chada, S. Mento, W. Edwards, 1996, Gene therapy.

Recombinant retroviral vector delivered intramuscularly localizes to the site of injection in mice.

S. Chada, S. Mento, D. Jolly, 1994, Human gene therapy.

Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma.

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer gene therapy.